JP2009544294A - Improved beverage - Google Patents
Improved beverage Download PDFInfo
- Publication number
- JP2009544294A JP2009544294A JP2009521179A JP2009521179A JP2009544294A JP 2009544294 A JP2009544294 A JP 2009544294A JP 2009521179 A JP2009521179 A JP 2009521179A JP 2009521179 A JP2009521179 A JP 2009521179A JP 2009544294 A JP2009544294 A JP 2009544294A
- Authority
- JP
- Japan
- Prior art keywords
- beverage
- weight
- beverage according
- amount
- sweetness
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013361 beverage Nutrition 0.000 title claims abstract description 96
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 claims abstract description 31
- 235000005487 catechin Nutrition 0.000 claims abstract description 31
- 235000013615 non-nutritive sweetener Nutrition 0.000 claims abstract description 26
- 229930006000 Sucrose Natural products 0.000 claims abstract description 7
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims abstract description 7
- 239000005720 sucrose Substances 0.000 claims abstract description 7
- 244000269722 Thea sinensis Species 0.000 claims description 28
- 239000000796 flavoring agent Substances 0.000 claims description 18
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 claims description 16
- 235000019634 flavors Nutrition 0.000 claims description 15
- 239000000203 mixture Substances 0.000 claims description 14
- 150000001765 catechin Chemical class 0.000 claims description 12
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 claims description 8
- 229960001948 caffeine Drugs 0.000 claims description 8
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 claims description 8
- 230000037237 body shape Effects 0.000 claims description 7
- 150000003839 salts Chemical class 0.000 claims description 7
- 244000099147 Ananas comosus Species 0.000 claims description 6
- 235000007119 Ananas comosus Nutrition 0.000 claims description 6
- 235000003599 food sweetener Nutrition 0.000 claims description 6
- 239000003765 sweetening agent Substances 0.000 claims description 6
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims description 5
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 5
- 239000001630 malic acid Substances 0.000 claims description 5
- 235000011090 malic acid Nutrition 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- 235000000346 sugar Nutrition 0.000 claims description 5
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 claims description 4
- 239000004376 Sucralose Substances 0.000 claims description 4
- 239000000619 acesulfame-K Substances 0.000 claims description 4
- 150000007524 organic acids Chemical class 0.000 claims description 4
- 235000019408 sucralose Nutrition 0.000 claims description 4
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical group O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 claims description 4
- 150000008163 sugars Chemical class 0.000 claims description 4
- 108010011485 Aspartame Proteins 0.000 claims description 3
- 239000000605 aspartame Substances 0.000 claims description 3
- 235000010357 aspartame Nutrition 0.000 claims description 3
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims description 3
- 229960003438 aspartame Drugs 0.000 claims description 3
- 235000013355 food flavoring agent Nutrition 0.000 claims description 3
- 239000008369 fruit flavor Substances 0.000 claims description 3
- 235000013399 edible fruits Nutrition 0.000 claims 1
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 abstract description 19
- 229950001002 cianidanol Drugs 0.000 abstract description 19
- 235000013616 tea Nutrition 0.000 description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 8
- 235000009569 green tea Nutrition 0.000 description 8
- 239000007787 solid Substances 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- 235000019640 taste Nutrition 0.000 description 6
- 235000019658 bitter taste Nutrition 0.000 description 5
- 150000001720 carbohydrates Chemical class 0.000 description 5
- AAWZDTNXLSGCEK-LNVDRNJUSA-N (3r,5r)-1,3,4,5-tetrahydroxycyclohexane-1-carboxylic acid Chemical compound O[C@@H]1CC(O)(C(O)=O)C[C@@H](O)C1O AAWZDTNXLSGCEK-LNVDRNJUSA-N 0.000 description 4
- AAWZDTNXLSGCEK-UHFFFAOYSA-N Cordycepinsaeure Natural products OC1CC(O)(C(O)=O)CC(O)C1O AAWZDTNXLSGCEK-UHFFFAOYSA-N 0.000 description 4
- AAWZDTNXLSGCEK-ZHQZDSKASA-N Quinic acid Natural products O[C@H]1CC(O)(C(O)=O)C[C@H](O)C1O AAWZDTNXLSGCEK-ZHQZDSKASA-N 0.000 description 4
- 235000006468 Thea sinensis Nutrition 0.000 description 4
- 239000011668 ascorbic acid Substances 0.000 description 4
- 229960005070 ascorbic acid Drugs 0.000 description 4
- 235000010323 ascorbic acid Nutrition 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 208000024172 Cardiovascular disease Diseases 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- -1 Phenyl hexyl Chemical group 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 235000015165 citric acid Nutrition 0.000 description 3
- XMOCLSLCDHWDHP-IUODEOHRSA-N epi-Gallocatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-IUODEOHRSA-N 0.000 description 3
- 230000007407 health benefit Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 description 2
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 240000009088 Fragaria x ananassa Species 0.000 description 2
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- XMOCLSLCDHWDHP-UHFFFAOYSA-N L-Epigallocatechin Natural products OC1CC2=C(O)C=C(O)C=C2OC1C1=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-UHFFFAOYSA-N 0.000 description 2
- 239000004384 Neotame Substances 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 210000000577 adipose tissue Anatomy 0.000 description 2
- 235000020279 black tea Nutrition 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 238000011088 calibration curve Methods 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- DZYNKLUGCOSVKS-UHFFFAOYSA-N epigallocatechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3cc(O)c(O)c(O)c3 DZYNKLUGCOSVKS-UHFFFAOYSA-N 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- LVJJFMLUMNSUFN-UHFFFAOYSA-N gallocatechin gallate Natural products C1=C(O)C=C2OC(C=3C=C(O)C(O)=CC=3)C(O)CC2=C1OC(=O)C1=CC(O)=C(O)C(O)=C1 LVJJFMLUMNSUFN-UHFFFAOYSA-N 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 2
- 238000010197 meta-analysis Methods 0.000 description 2
- 235000019412 neotame Nutrition 0.000 description 2
- HLIAVLHNDJUHFG-HOTGVXAUSA-N neotame Chemical compound CC(C)(C)CCN[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 HLIAVLHNDJUHFG-HOTGVXAUSA-N 0.000 description 2
- 108010070257 neotame Proteins 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 150000005846 sugar alcohols Chemical class 0.000 description 2
- XMOCLSLCDHWDHP-SWLSCSKDSA-N (+)-Epigallocatechin Natural products C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-SWLSCSKDSA-N 0.000 description 1
- LSHVYAFMTMFKBA-PZJWPPBQSA-N (+)-catechin-3-O-gallate Chemical compound O([C@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=CC=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-PZJWPPBQSA-N 0.000 description 1
- PFTAWBLQPZVEMU-ZFWWWQNUSA-N (+)-epicatechin Natural products C1([C@@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-ZFWWWQNUSA-N 0.000 description 1
- WMBWREPUVVBILR-GHTZIAJQSA-N (+)-gallocatechin gallate Chemical compound O([C@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-GHTZIAJQSA-N 0.000 description 1
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 description 1
- PFTAWBLQPZVEMU-UKRRQHHQSA-N (-)-epicatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-UKRRQHHQSA-N 0.000 description 1
- LSHVYAFMTMFKBA-TZIWHRDSSA-N (-)-epicatechin-3-O-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=CC=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-TZIWHRDSSA-N 0.000 description 1
- GHBNZZJYBXQAHG-KUVSNLSMSA-N (2r,3r,4s,5s,6r)-2-[[(2r,3s,4s,5r,6r)-6-[[(3s,8s,9r,10r,11r,13r,14s,17r)-17-[(2r,5r)-5-[(2s,3r,4s,5s,6r)-4,5-dihydroxy-3-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@H](CC[C@@H](C)[C@@H]1[C@]2(C[C@@H](O)[C@@]3(C)[C@H]4C(C([C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]6[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O6)O)O5)O)CC4)(C)C)=CC[C@H]3[C@]2(C)CC1)C)C(C)(C)O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GHBNZZJYBXQAHG-KUVSNLSMSA-N 0.000 description 1
- RCSBILYQLVXLJG-UHFFFAOYSA-N 2-Propenyl hexanoate Chemical compound CCCCCC(=O)OCC=C RCSBILYQLVXLJG-UHFFFAOYSA-N 0.000 description 1
- 235000009434 Actinidia chinensis Nutrition 0.000 description 1
- 244000298697 Actinidia deliciosa Species 0.000 description 1
- 235000009436 Actinidia deliciosa Nutrition 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 235000004936 Bromus mango Nutrition 0.000 description 1
- 240000003538 Chamaemelum nobile Species 0.000 description 1
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 241001672694 Citrus reticulata Species 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 description 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 description 1
- 235000009685 Crataegus X maligna Nutrition 0.000 description 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 description 1
- 235000009486 Crataegus bullatus Nutrition 0.000 description 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 description 1
- 235000009682 Crataegus limnophila Nutrition 0.000 description 1
- 240000000171 Crataegus monogyna Species 0.000 description 1
- 235000004423 Crataegus monogyna Nutrition 0.000 description 1
- 235000002313 Crataegus paludosa Nutrition 0.000 description 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- HEBKCHPVOIAQTA-QWWZWVQMSA-N D-arabinitol Chemical compound OC[C@@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-QWWZWVQMSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- LSHVYAFMTMFKBA-UHFFFAOYSA-N ECG Natural products C=1C=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 239000001512 FEMA 4601 Substances 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 241000404095 Heteranthemis Species 0.000 description 1
- 235000005206 Hibiscus Nutrition 0.000 description 1
- 235000007185 Hibiscus lunariifolius Nutrition 0.000 description 1
- 244000284380 Hibiscus rosa sinensis Species 0.000 description 1
- ZMJBYMUCKBYSCP-UHFFFAOYSA-N Hydroxycitric acid Chemical compound OC(=O)C(O)C(O)(C(O)=O)CC(O)=O ZMJBYMUCKBYSCP-UHFFFAOYSA-N 0.000 description 1
- 235000010254 Jasminum officinale Nutrition 0.000 description 1
- 240000005385 Jasminum sambac Species 0.000 description 1
- 108010029541 Laccase Proteins 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241000220225 Malus Species 0.000 description 1
- 235000011430 Malus pumila Nutrition 0.000 description 1
- 235000015103 Malus silvestris Nutrition 0.000 description 1
- 235000014826 Mangifera indica Nutrition 0.000 description 1
- 240000007228 Mangifera indica Species 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- HLDYLAJAWSKPFZ-UHFFFAOYSA-N Monoglucuronylglycyrrhetinic acid Chemical compound C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1O HLDYLAJAWSKPFZ-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 235000000370 Passiflora edulis Nutrition 0.000 description 1
- 244000288157 Passiflora edulis Species 0.000 description 1
- KYZGSVXLJRVXSE-UHFFFAOYSA-N Periandrin IV Natural products CC1(C)C(CCC2(CO)C1CCC3(C)C2CC=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(C(O)C(O)C7O)C(=O)O)C(=O)O KYZGSVXLJRVXSE-UHFFFAOYSA-N 0.000 description 1
- 108700020962 Peroxidase Proteins 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 241000508269 Psidium Species 0.000 description 1
- 235000014443 Pyrus communis Nutrition 0.000 description 1
- 240000001987 Pyrus communis Species 0.000 description 1
- HELXLJCILKEWJH-SEAGSNCFSA-N Rebaudioside A Natural products O=C(O[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@@]1(C)[C@@H]2[C@](C)([C@H]3[C@@]4(CC(=C)[C@@](O[C@H]5[C@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@H](O)[C@@H](CO)O5)(C4)CC3)CC2)CCC1 HELXLJCILKEWJH-SEAGSNCFSA-N 0.000 description 1
- 235000004789 Rosa xanthina Nutrition 0.000 description 1
- 241000109329 Rosa xanthina Species 0.000 description 1
- 240000007651 Rubus glaucus Species 0.000 description 1
- 235000011034 Rubus glaucus Nutrition 0.000 description 1
- 235000009122 Rubus idaeus Nutrition 0.000 description 1
- 241001362551 Samba Species 0.000 description 1
- 235000009184 Spondias indica Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 240000006909 Tilia x europaea Species 0.000 description 1
- 240000001717 Vaccinium macrocarpon Species 0.000 description 1
- 235000012545 Vaccinium macrocarpon Nutrition 0.000 description 1
- 235000002118 Vaccinium oxycoccus Nutrition 0.000 description 1
- 235000007212 Verbena X moechina Moldenke Nutrition 0.000 description 1
- 240000001519 Verbena officinalis Species 0.000 description 1
- 235000001594 Verbena polystachya Kunth Nutrition 0.000 description 1
- 235000007200 Verbena x perriana Moldenke Nutrition 0.000 description 1
- 235000002270 Verbena x stuprosa Moldenke Nutrition 0.000 description 1
- 229930003571 Vitamin B5 Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000002535 acidifier Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 230000000595 bitter masking effect Effects 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229960004106 citric acid Drugs 0.000 description 1
- 238000002485 combustion reaction Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000004634 cranberry Nutrition 0.000 description 1
- 229940109275 cyclamate Drugs 0.000 description 1
- HCAJEUSONLESMK-UHFFFAOYSA-N cyclohexylsulfamic acid Chemical compound OS(=O)(=O)NC1CCCCC1 HCAJEUSONLESMK-UHFFFAOYSA-N 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- HELXLJCILKEWJH-UHFFFAOYSA-N entered according to Sigma 01432 Natural products C1CC2C3(C)CCCC(C)(C(=O)OC4C(C(O)C(O)C(CO)O4)O)C3CCC2(C2)CC(=C)C21OC(C1OC2C(C(O)C(O)C(CO)O2)O)OC(CO)C(O)C1OC1OC(CO)C(O)C(O)C1O HELXLJCILKEWJH-UHFFFAOYSA-N 0.000 description 1
- LPTRNLNOHUVQMS-UHFFFAOYSA-N epicatechin Natural products Cc1cc(O)cc2OC(C(O)Cc12)c1ccc(O)c(O)c1 LPTRNLNOHUVQMS-UHFFFAOYSA-N 0.000 description 1
- 235000012734 epicatechin Nutrition 0.000 description 1
- 229940030275 epigallocatechin gallate Drugs 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 235000008995 european elder Nutrition 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 235000006486 human diet Nutrition 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 229940089491 hydroxycitric acid Drugs 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 210000001596 intra-abdominal fat Anatomy 0.000 description 1
- 239000000905 isomalt Substances 0.000 description 1
- 235000010439 isomalt Nutrition 0.000 description 1
- HPIGCVXMBGOWTF-UHFFFAOYSA-N isomaltol Natural products CC(=O)C=1OC=CC=1O HPIGCVXMBGOWTF-UHFFFAOYSA-N 0.000 description 1
- 239000000832 lactitol Substances 0.000 description 1
- 235000010448 lactitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 description 1
- 229960003451 lactitol Drugs 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 235000001055 magnesium Nutrition 0.000 description 1
- 229940091250 magnesium supplement Drugs 0.000 description 1
- 229940099690 malic acid Drugs 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229960001855 mannitol Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- TVJXHJAWHUMLLG-UHFFFAOYSA-N mogroside V Natural products CC(CCC(OC1OC(COC2OC(CO)C(O)C(O)C2OC3OC(CO)C(O)C(O)C3O)C(O)C(O)C1O)C(C)(C)O)C4CCC5(C)C6CC=C7C(CCC(OC8OC(COC9OC(CO)C(O)C(O)C9O)C(O)C(O)C8O)C7(C)C)C6(C)C(O)CC45C TVJXHJAWHUMLLG-UHFFFAOYSA-N 0.000 description 1
- ARGKVCXINMKCAZ-UZRWAPQLSA-N neohesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O[C@H]3[C@@H]([C@H](O)[C@@H](O)[C@H](C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UZRWAPQLSA-N 0.000 description 1
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 235000020733 paullinia cupana extract Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 235000019203 rebaudioside A Nutrition 0.000 description 1
- 238000004007 reversed phase HPLC Methods 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 229940013618 stevioside Drugs 0.000 description 1
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- 235000021012 strawberries Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 229960001367 tartaric acid Drugs 0.000 description 1
- 239000000892 thaumatin Substances 0.000 description 1
- 235000010436 thaumatin Nutrition 0.000 description 1
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
- 229940038773 trisodium citrate Drugs 0.000 description 1
- 235000009492 vitamin B5 Nutrition 0.000 description 1
- 239000011675 vitamin B5 Substances 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 238000004260 weight control Methods 0.000 description 1
- 230000037221 weight management Effects 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/16—Tea extraction; Tea extracts; Treating tea extract; Making instant tea
- A23F3/163—Liquid or semi-liquid tea extract preparations, e.g. gels, liquid extracts in solid capsules
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/30—Artificial sweetening agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Dispersion Chemistry (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Tea And Coffee (AREA)
- Non-Alcoholic Beverages (AREA)
Abstract
100g当たり17kJ未満の全エネルギー含量を有する飲料であって、飲料の0.04〜0.4重量%の量(C)のカテキンと、栄養価のない甘味料を以下の条件:
34 < (S/C) < 115、
[ここで、Sはスクロースに換算した栄養価のない甘味料の甘さである]
を満足する量において含む飲料。A beverage having a total energy content of less than 17 kJ per 100 g, with a catechin in an amount (C) of 0.04 to 0.4% by weight of the beverage and a non-nutritive sweetener under the following conditions:
34 <(S / C) <115,
[Where S is the sweetness of a non-nutritive sweetener converted to sucrose]
In a quantity that satisfies the beverage.
Description
本発明は飲料に関する。とりわけ、本発明は、カテキンを含む飲料、例えば、茶系飲料に関する。 The present invention relates to beverages. In particular, the present invention relates to beverages containing catechins, such as tea-based beverages.
緑茶は何千年にも亘り、中国および日本で消費されてきた人気の高い飲料である。最近、実験室における大規模な研究、および、疫学的研究により、緑茶に存在する化合物(特に、カテキン)が、様々な疾病の危険を減少させうることが分かってきた。さらに、カテキンは、内臓脂肪の蓄積を抑制し、そのため、体重および体型の制御に役立つことが明らかにされている(例えば、T.Nagaoらによる、”Tea Catechins Suppress Accumulation of Body Fat in Humans”, J. Oleo. Sci., 2001, 50(9), pp.717-728を参照)。これらの研究と、日々に複雑さを増す消費者の味覚により緑茶の消費が増加し、その増加は緑茶消費の伝統のない市場(例えば、合衆国および西欧諸国)においてさえみられる。 Green tea is a popular beverage that has been consumed in China and Japan for thousands of years. Recently, extensive laboratory and epidemiological studies have shown that compounds present in green tea (especially catechins) can reduce the risk of various diseases. In addition, catechins have been shown to suppress visceral fat accumulation and thus help control body weight and body shape (eg, “Tea Catechins Suppress Accumulation of Body Fat in Humans”, by T. Nagao et al., J. Oleo. Sci., 2001, 50 (9), pp. 717-728). These studies and consumer tastes of increasing complexity on a daily basis increase green tea consumption, even in markets where there is no tradition of green tea consumption (eg, the United States and Western countries).
茶の健康上の利点の一部は一日三杯程の低い消費率においてさえ明白なものであるが(例えば、U.Petersらによる、“Does tea affect cardiovascular disease? A meta-analysis.”, American Journal of Epidemiology, 2001, 154, pp.495-503参照)、多くの個人はこの少量の消費率さえ、長期的に達成することはない。 Some of the health benefits of tea are evident even at low rates of consumption of as little as 3 cups a day (eg, “Does tea affect cardiovascular disease? A meta-analysis.”, By U. Peters et al., American Journal of Epidemiology, 2001, 154 , pp.495-503), many individuals do not achieve even this small consumption rate in the long term.
増加したレベルのカテキンを含む飲料を提供するための試みがいくつかなされてきた。 Several attempts have been made to provide beverages containing increased levels of catechins.
欧州特許第0 762 836 B号明細書は、緑茶固形物と、一定のレベルのある種の電解質と炭水化物とを組み合わせることにより、細胞水和と飲み易さが向上した飲料について開示する。しかし、不幸にも、飲料における顕著なレベルの炭水化物の存在は、カテキンによりもたらされるある種の利点を台無しにしてしまう。特に、糖類の高いエネルギーへの寄与が、体重および/または体型の制御の点において、カテキンの利点の影響を弱める傾向にあるだろう。 EP 0 762 836 B discloses a beverage with improved cell hydration and ease of drinking by combining green tea solids with certain levels of certain electrolytes and carbohydrates. Unfortunately, however, the presence of significant levels of carbohydrates in the beverage messed up certain benefits provided by catechins. In particular, the high energy contribution of sugars will tend to weaken the impact of catechin benefits in terms of body weight and / or body shape control.
欧州特許出願公開第1 297 749 A号明細書は、濃縮または精製した茶抽出物を含む飲料であって、0.092〜0.5重量%のカテキンと、カテキンに対して特定の重量比のキナ酸を含む飲料を開示する。当該飲料は向上した味覚を有すと言われ、カテキンに特有の苦みや渋みが甘味料により軽減された後に本来なら残ってしまう、不快な後味を残さない。しかし、そこに開示される飲料は、それ自体が望ましくない味覚を飲料にもたらしうる、キナ酸の添加を必要とする。さらに、当該飲料は、比較的低いレベルのカテキンを有する、紅茶等の茶系飲料に慣れている消費者にとっては、依然として不快な程苦い。 EP 1 297 749 A is a beverage comprising a concentrated or purified tea extract comprising 0.092-0.5% by weight catechin and a specific weight ratio of quinic acid to catechin. A beverage is disclosed. The beverage is said to have an improved taste and does not leave an unpleasant aftertaste that would otherwise remain after the bitterness and astringency unique to catechins have been reduced by sweeteners. However, the beverages disclosed therein require the addition of quinic acid, which itself can bring undesirable taste to the beverage. Furthermore, the beverage is still unpleasantly bitter for consumers accustomed to tea-based beverages, such as black tea, having a relatively low level of catechins.
従って、我々は高いレベルのカテキンの利点、特に、体重および/または体型の管理における利点をもたらし、特に苦みについての改良した味覚を有する飲料を提供する要求があることを認識した。 Thus, we have recognized that there is a need to provide beverages with the benefits of high levels of catechins, particularly in weight and / or body shape management, especially with an improved taste for bitterness.
我々は、特定の組成を有する飲料を提供することにより、これらの要求が満たされうることを認識した。 We have recognized that these requirements can be met by providing beverages with specific compositions.
試験および定義
飲料
ここで使用される「飲料」の語は、人間の消費に適した、実質的に水性の飲用可能な組成物について言及するものである。好ましくは、飲料は、当該飲料の、少なくとも85重量%の水を含み、より好ましくは90重量%、最も好ましくは95〜99.9重量%の水を含む。
Tests and Definitions Beverage The term “beverage” as used herein refers to a substantially aqueous drinkable composition suitable for human consumption. Preferably, the beverage comprises at least 85% water by weight of the beverage, more preferably 90%, most preferably 95-99.9% water.
茶固形物
ここで使用される「茶固形物」の語は、植物であるCamellia sinensis var. sinensis、および/または、Camellia sinensis var. assamicaの葉からの乾燥物質抽出物について言及するものである。これらの葉は、「紅茶」製造の初期の段階において放出される、ある種の内因性酵素により酸化がなされる、いわゆる、「発酵」工程を経たものであってよい。この酸化は、オキシダーゼ、ラッカーゼ、およびペルオキシダーゼ等の内因性酵素により補足されてもよい。その代わりに、葉は、部分的に発酵されたもの(「ウーロン」茶)でもよく、または実質的に発酵されていないもの(「緑茶」)でもよい。
Tea solids As used herein, the term “tea solids” refers to dry matter extracts from the leaves of the plants Camellia sinensis var. Sinensis and / or Camellia sinensis var. Assamica. These leaves may have undergone a so-called “fermentation” process that is oxidized by certain endogenous enzymes released in the early stages of “black tea” production. This oxidation may be supplemented by endogenous enzymes such as oxidases, laccases, and peroxidases. Alternatively, the leaves may be partially fermented (“oolong” tea) or substantially unfermented (“green tea”).
茶系飲料
ここで使用される「茶系飲料」の語は、当該飲料の、少なくとも0.01重量%の茶固形物を含む飲料について言及するものである。好ましくは、茶系飲料は、0.04〜3重量%の茶固形物を含み、より好ましくは0.06〜2重量%、最も好ましくは0.1〜1重量%の茶固形物を含む。
Tea-based beverage The term “tea-based beverage” as used herein refers to a beverage containing at least 0.01 wt% tea solids of the beverage. Preferably, the tea-based beverage contains 0.04 to 3 wt% tea solids, more preferably 0.06 to 2 wt%, most preferably 0.1 to 1 wt% tea solids.
カテキン
ここで使用される「カテキン」の語は、カテキン、ガロカテキン、カテキンガラート、ガロカテキンガラート、エピカテキン、エピガロカテキン、エピカテキンガラート、エピガロカテキンガラート、およびこれらの混合物の一般名称として用いられる。
Catechin As used herein, the term “catechin” refers generally to catechin, gallocatechin, catechin gallate, gallocatechin gallate, epicatechin, epigallocatechin, epicatechin gallate, epigallocatechin gallate, and mixtures thereof. Used as a name.
飲料中のカテキンおよびカフェインの測定
飲料中のカテキンおよびカフェインの量は、以下により、逆相高速液体クロマトグラフィー(HPLC)により、同時に決定される。
Determination of catechin and caffeine in beverages The amount of catechin and caffeine in beverages is determined simultaneously by reverse phase high performance liquid chromatography (HPLC) by:
サンプル調製
飲料(9ml)を取り分け、アセトニトリル(1.12ml)を、蒸留水による、2.5mg/ml EDTAと2.5mg/mlアスコルビン酸の溶液(1.12ml)と伴に添加した。得られた液体の上澄みを、その後、微小遠心管に注ぎ、10分間に亘り、14000gの相対遠心力で遠心分離をした。
Sample preparation Beverage (9 ml) was dispensed and acetonitrile (1.12 ml) was added along with a solution of 2.5 mg / ml EDTA and 2.5 mg / ml ascorbic acid in distilled water (1.12 ml). The resulting liquid supernatant was then poured into a microcentrifuge tube and centrifuged at 14000 g relative centrifugal force for 10 minutes.
HPLC分析条件
カラム:Luna Phenyl hexyl 5μ, 250 x 4.60 mm
流速:1 ml/min
オーブン温度:30℃
溶媒:A:アセトニトリル中の2%酢酸
B:水中の2%酢酸および0.02mg/ml EDTA
注入体積:10μl
勾配:
HPLC analysis conditions Column: Luna Phenyl hexyl 5μ, 250 x 4.60 mm
Flow rate: 1 ml / min
Oven temperature: 30 ℃
Solvent: A: 2% acetic acid in acetonitrile B: 2% acetic acid in water and 0.02 mg / ml EDTA
Injection volume: 10μl
Slope:
定量化:
検量線に対するピーク面積を毎日作成した。検量線はカフェインから作成し、カテキンの濃度はカフェインに対する個々のカテキンの相対感度を用いて計算した(ISOカテキン法による−ISO/CD 14502-2)。個々のカフェイン基準(standards)(Sigma, Poole, Dorset, UK)を、ピーク特定マーカーとして使用した。
Quantification:
A peak area for the calibration curve was created daily. A calibration curve was prepared from caffeine, and the concentration of catechin was calculated using the relative sensitivity of each catechin to caffeine (ISO / CD 14502-2 by ISO catechin method). Individual caffeine standards (Sigma, Poole, Dorset, UK) were used as peak specific markers.
糖類:
ここで使用される「糖類」の語は、専ら、消化可能なモノ−およびジ−サッカリド類のみについて言及するものである。
この語は、茶固形物、ミルク、およびフルーツジュースからのあらゆる糖を含む。
Sugars:
As used herein, the term “saccharide” refers exclusively to digestible mono- and di-saccharides.
The term includes any sugar from tea solids, milk, and fruit juice.
全エネルギー含量
飲料の全エネルギー含量(E)は、100gの飲料に存在する成分の代謝可能なエネルギーの総和として規定され、式1
を用いて計算される。
Total energy content The total energy content (E) of a beverage is defined as the sum of the metabolizable energy of the components present in a 100 g beverage,
Is calculated using
消化可能なサッカリド類とタンパク質については、fjは典型的にg当たり16.7kJ(4.0 kcal)であり、脂肪については、g当たり37.7kJ(9.0 kcal)である。 For digestible saccharides and proteins, f j is typically 16.7 kJ (4.0 kcal) per g and for fat 37.7 kJ (9.0 kcal) per g.
カロリー変換因子は成分の製造業者から容易に利用可能である。もう一つの方法としては、当該因子は、食物材料の組成と燃焼熱を、当該材料の老廃物のそれらと比較することにより決定してもよい(D.A.T. Southgate and J.V.G.A. Durnin, “Calorie conversion factors. An experimental reassessment of the factors used in the calculation of the energy value of human diets.”, British Journal of Nutrition, 1970, 24, pp. 517-535を参照)。 Calorie conversion factors are readily available from component manufacturers. Alternatively, the factors may be determined by comparing the composition of the food material and the heat of combustion with those of the material waste (DAT Southgate and JVGA Durnin, “Calorie conversion factors. An experimental reassessment of the factors used in the calculation of the energy value of human diets. ”, British Journal of Nutrition, 1970, 24, pp. 517-535).
栄養価のない甘味料
栄養価のない甘味料は、強力(intense)甘味料、糖アルコール類、およびこれらの混合物からなる。強力甘味料は、少なくとも10の相対甘さ、より好ましくは30から30000の相対甘さを有する材料である。強力甘味料はアスパルテーム、サッカリン、アセサルフェーム K、アリテーム(alimate)、タウマチン(thaumatin)、チクロ(cyclamate)、グリシルリジン(glycyrrhizin)、ステビオシド(stevioside)、ネオヘスペリジン(neohesperidine)、スクラロース、モネリン、ネオテーム(neotame)、モグロサイド V、MGGR、ペリアンドリン I-V、リバウディオサイド A(rebaudioside A)、ステビア抽出物、およびこれらの混合物を含む。糖アルコール類は、HSH(水素化デンプン加水分解物−ポリグリシトールとしても知られる)、エリトリトール、アラビトール、グリセロール、キシリトール、ソルビトール、マンニトール、ラクチトール(lactitol)、マルチトール(maltitol)、イソマルト(isomalt)、パラチニット(palatinit)、およびこれらの混合物を含む。
Non-nutritive sweeteners Non-nutritive sweeteners consist of intense sweeteners, sugar alcohols, and mixtures thereof. An intense sweetener is a material having a relative sweetness of at least 10 and more preferably a relative sweetness of 30 to 30000. Intense sweeteners include aspartame, saccharin, acesulfame K, alimate, thaumatin, cyclamate, glycyrrhizin, stevioside, neohesperidin, sucralose, monelin, neotame ( neotame), mogroside V, MGGR, periandrin IV, rebaudioside A, stevia extract, and mixtures thereof. Sugar alcohols are HSH (hydrogenated starch hydrolyzate-also known as polyglycitol), erythritol, arabitol, glycerol, xylitol, sorbitol, mannitol, lactitol, maltitol, isomalt , Palatinit, and mixtures thereof.
甘さ
ここに規定する通り、相対甘さRiは、等量のスクロースの甘さに対する、物質iの甘さについて言及する(つまり、スクロースは1の相対的甘さを有する)。これは、食品産業において甘さを表現するために一般的に用いられる手法である。ある種の栄養価のない甘味料の相対甘さを表1に示す。
Sweetness As defined herein, relative sweetness R i refers to the sweetness of substance i relative to the equivalent sweetness of sucrose (ie, sucrose has a relative sweetness of 1). This is a technique commonly used to express sweetness in the food industry. Table 1 shows the relative sweetness of certain non-nutritive sweeteners.
mi(飲料の重量%)の量で存在する栄養価のない甘味料の、スクロースに換算した甘さSiは、相対甘さと量の積、つまり、Si = Rimiである。よって、非サッカリド甘味料の混合物について、スクロース(S)に換算した甘さは式2により定義される。
[発明の概要]
第一の態様においては、本発明は100g当たり17kJ未満の全エネルギー含量を有する飲料であって、飲料の0.04〜0.4重量%の量(C)のカテキンと、栄養価のない甘味料を以下の条件:
34 < (S/C) < 115
[ここで、Sはスクロースに換算した栄養価のない甘味料の甘さである]
を満足する量において含む飲料を提供する。
[Summary of Invention]
In a first aspect, the present invention is a beverage having a total energy content of less than 17 kJ per 100 g, the catechin in an amount (C) of 0.04 to 0.4% by weight of the beverage, and a non-nutritive sweetener comprising: conditions:
34 <(S / C) <115
[Where S is the sweetness of a non-nutritive sweetener converted to sucrose]
In a quantity that satisfies the requirements.
我々は、これらの飲料が、甘さと苦みに関して、バランスに優れた香味をもたらすことを発見した。比(S/C)は105未満であることが好ましく、より好ましくは95未満、最も好ましくは85未満である。また、好ましくは、比(S/C)は少なくとも37、より好ましくは少なくとも40、最も好ましくは少なくとも45である。 We have found that these beverages provide a balanced flavor with respect to sweetness and bitterness. The ratio (S / C) is preferably less than 105, more preferably less than 95, and most preferably less than 85. Also preferably, the ratio (S / C) is at least 37, more preferably at least 40, most preferably at least 45.
我々は、本発明の飲料は、相対的に低いレベルの甘さにおいても、バランスに優れた香味を有することが可能であることを発見した。従って、甘さ(S)は飲料の10重量%未満であることが好ましく、より好ましくは7重量%未満であり、最も好ましくは5重量%未満である。また、甘さは飲料の少なくとも1重量%であることが好ましく、より好ましくは少なくとも2重量%であり、最も好ましくは少なくとも3重量%である。 We have found that the beverages of the present invention can have a well-balanced flavor even at relatively low levels of sweetness. Accordingly, the sweetness (S) is preferably less than 10% by weight of the beverage, more preferably less than 7% by weight, and most preferably less than 5% by weight. Also, the sweetness is preferably at least 1% by weight of the beverage, more preferably at least 2% by weight, and most preferably at least 3% by weight.
驚くべきことに、我々は、本発明の飲料は、キナ酸等の苦みマスキング剤がなくともバランスに優れた香味を有することを発見した。従って、本発明の飲料は好ましくは添加されたキナ酸を含まない。 Surprisingly, we have found that the beverage of the present invention has a well-balanced flavor without a bitter masking agent such as quinic acid. Accordingly, the beverage of the present invention is preferably free of added quinic acid.
飲料の健康上の利点を最大化するために、好ましくは、カテキンの量(C)は飲料の少なくとも0.05重量%、より好ましくは少なくとも0.06重量%である。苦みを最小限とするために、カテキンの量は飲料の0.3重量%未満であることが好ましく、より好ましくは0.2重量%未満である。 In order to maximize the health benefits of the beverage, preferably the amount of catechin (C) is at least 0.05%, more preferably at least 0.06% by weight of the beverage. In order to minimize bitterness, the amount of catechin is preferably less than 0.3% by weight of the beverage, more preferably less than 0.2% by weight.
飲料の低いエネルギー含量は、不健康な量となるカロリーをもたらすことなく、カテキンの健康上の利点を送達することを許容する。全エネルギー含量が100g当たり5kJ未満であることが好ましく、より好ましくは100g当たり2kJ未満であり、最も好ましくは100g当たり0.0001〜1kJである。 The low energy content of the beverage allows the health benefits of catechin to be delivered without producing unhealthy calories. It is preferred that the total energy content is less than 5 kJ per 100 g, more preferably less than 2 kJ per 100 g, most preferably 0.0001 to 1 kJ per 100 g.
飲料の甘さは主に栄養価のない甘味料により提供されるため、飲料は糖類を飲料の0.25重量%未満の量で含むことが好ましく、より好ましくは0.1重量%未満、最も好ましくは0.001〜0.05重量%で含む。 Since the sweetness of the beverage is mainly provided by non-nutritive sweeteners, the beverage preferably contains sugars in an amount of less than 0.25% by weight of the beverage, more preferably less than 0.1% by weight, most preferably 0.001 to Contains at 0.05% by weight.
栄養価のない甘味料の濃度はカテキンの量および上記の甘味料の相対的甘さに依存することとなる。しかし、典型的には、飲料は、その飲料の0.00001〜10重量%の量において栄養価のない甘味料を含み、より好ましくは0.001〜1重量%の量において、最も好ましくは0.01〜0.1重量%の量において栄養価のない甘味料を含むだろう。 The concentration of non-nutritive sweetener will depend on the amount of catechin and the relative sweetness of the sweetener. Typically, however, the beverage comprises a non-nutritive sweetener in an amount of 0.00001-10% by weight of the beverage, more preferably in an amount of 0.001-1%, most preferably 0.01-0.1% by weight. Will contain non-nutritive sweeteners in the amount of.
甘味料のエネルギーへの貢献を最小化するために、栄養価のない甘味料は強力甘味料を含むことが好ましい。好ましくは、栄養価のない甘味料は、栄養価のない甘味料に対して、少なくとも50重量%、より好ましくは少なくとも75重量%、最も好ましくは90〜100重量%の強力甘味料を含む。最も好ましい強力甘味料は、そのまろやかな香味により、スクラロース、アスパルテーム、アセサルフェーム K、またはこれらの混合物である。 In order to minimize the energy contribution of the sweetener, the non-nutritive sweetener preferably comprises an intense sweetener. Preferably, the non-nutritive sweetener comprises at least 50% by weight, more preferably at least 75% by weight and most preferably 90-100% by weight of the intense sweetener relative to the non-nutritive sweetener. The most preferred intense sweetener is sucralose, aspartame, acesulfame K, or a mixture thereof, depending on its mild flavor.
我々は、上記の甘味料のカテキンに対する比率は、爽やかであるが苦すぎない茶系飲料をもたらすのにとりわけふさわしいことを発見した。従って、飲料は茶系飲料であることが好ましく、好ましくは緑茶系飲料である。 We have found that the above ratio of sweetener to catechin is particularly suitable for providing tea-based beverages that are refreshing but not too bitter. Therefore, the beverage is preferably a tea beverage, and is preferably a green tea beverage.
微生物安定性および味覚の点より、飲料は酸性のpHを有することが好ましい。特に、(20℃における)pHは2〜5であってよく、より好ましくは2.5〜4.5、最も好ましくは3〜4である。 From the viewpoint of microbial stability and taste, the beverage preferably has an acidic pH. In particular, the pH (at 20 ° C.) may be 2-5, more preferably 2.5-4.5, most preferably 3-4.
適切な酸性化剤はクエン酸、リンゴ酸、酒石酸、アスコルビン酸、これらの塩等の有機酸、およびこれらの混合物を含む。上記酸がリンゴ酸および/またはこれらの塩を含む時、特にバランスの良い香味を得ることができる。クエン酸(および/またはその塩)、リンゴ酸(および/またはその塩)、およびアスコルビン酸(および/またはその塩)の混合物もまた、良好な香味を提供する。典型的には、飲料における有機酸および/または塩の濃度は、0.001〜1%であり、より好ましくは、0.01〜0.5%である。 Suitable acidifying agents include citric acid, malic acid, tartaric acid, ascorbic acid, organic acids such as their salts, and mixtures thereof. When the acid contains malic acid and / or a salt thereof, a particularly well-balanced flavor can be obtained. A mixture of citric acid (and / or its salt), malic acid (and / or its salt), and ascorbic acid (and / or its salt) also provides a good flavor. Typically, the concentration of organic acid and / or salt in the beverage is 0.001-1%, more preferably 0.01-0.5%.
飲料は好ましくは香味料を含む。適切な香味料は天然および合成の果物の香味料、および/または、天然または合成の草本の香味料を含む。果物の香味料の例は、リンゴ、桃、梨、レモン、ライム、マンダリン、グレープフルーツ、クランベリー、オレンジ、イチゴ、葡萄、キウイ、パイナップル、パッションフルーツ、マンゴー、グァバ、ラズベリー、およびサンランボを含む。草本の香味料の例は、ジャスミン、カモミール、バラ、ミント、サンザシ、キク、モクセイ、ハイビスカス、ニワトコの花、およびバーベナを含む。驚くべきことに、我々はパイナップルの香味料(天然または合成)はカテキンの苦みをマスクするのにとりわけ効果的であることを発見し、従って香味料がパイナップルの香味料を含むことがとりわけ好ましい。パイナップの香味料は天然または合成のいずれでもよい。好ましくは、パイナップルの香味料は2-プロペニルヘキサノエートを含む。香味料の量は、好ましくは、飲料の0.001〜0.5重量%、より好ましくは、0.05〜0.19重量%である。 The beverage preferably contains a flavoring agent. Suitable flavors include natural and synthetic fruit flavors and / or natural or synthetic herbal flavors. Examples of fruit flavors include apple, peach, pear, lemon, lime, mandarin, grapefruit, cranberry, orange, strawberry, strawberries, kiwi, pineapple, passion fruit, mango, guava, raspberry, and samba. Examples of herbal flavors include jasmine, chamomile, roses, mint, hawthorn, chrysanthemum, oxeye, hibiscus, elderflower, and verbena. Surprisingly, we have found that pineapple flavors (natural or synthetic) are particularly effective in masking catechin bitterness, and it is therefore particularly preferred that the flavor comprises a pineapple flavor. Pineapple flavors may be either natural or synthetic. Preferably, the pineapple flavoring comprises 2-propenylhexanoate. The amount of flavoring is preferably 0.001 to 0.5% by weight of the beverage, more preferably 0.05 to 0.19%.
飲料は、付加的または代替的に、体重管理活性成分を含んでもよい。適切な活性成分はビオチン、パントテン酸(ビタミンB5)、ビタミンB6、ナイアシン、マグネシウム、ゼルバ・マテ抽出物、ガラナ抽出物、ヒドロキシクエン酸、およびこれらの混合物を含む。 The beverage may additionally or alternatively include a weight management active ingredient. Suitable active ingredients include biotin, pantothenic acid (vitamin B5), vitamin B6, niacin, magnesium, zelva mate extract, guarana extract, hydroxycitric acid, and mixtures thereof.
最も好ましい態様においては、飲料はカフェインを、飲料の重量に対し、0.001〜0.1重量%、より好ましくは、0.005〜0.05重量%の量において含む。身体管理、とりわけ体重制御および/または体型制御を補助することが分かっているため、カフェインは特に好ましい。 In the most preferred embodiment, the beverage comprises caffeine in an amount of 0.001 to 0.1 wt%, more preferably 0.005 to 0.05 wt%, based on the weight of the beverage. Caffeine is particularly preferred because it has been found to assist physical management, especially weight control and / or body shape control.
本発明の飲料は医薬として、または、医薬の調製に用いてもよい。特に、飲料は、カテキンの消費に関連する利点を提供するため、例えば、癌の治療および/または予防、および/または、心臓血管の病気の治療および/または予防のために用いてもよい。特に、個人の体重および/または体型を制御するための飲料を使用することが好ましい。例えば、飲料はこれらの利点の少なくとも1つを個人に提供する方法であって、個人に上記飲料を投与することを含む方法に用いてもよい。好ましくは、飲料は経口投与される。 The beverage of the present invention may be used as a medicine or for the preparation of a medicine. In particular, the beverage may be used, for example, for the treatment and / or prevention of cancer and / or for the treatment and / or prevention of cardiovascular disease, in order to provide benefits related to consumption of catechins. In particular, it is preferable to use a beverage for controlling an individual's weight and / or body shape. For example, a beverage may be used in a method that provides an individual with at least one of these benefits, including administering the beverage to the individual. Preferably the beverage is administered orally.
[詳細な説明]
本発明を以下の例を用いてさらに説明する。
[Detailed description]
The invention is further illustrated by the following examples.
表2の配合を有する5つの飲料製品を製造した。 Five beverage products having the formulation of Table 2 were produced.
製品は以下のプロトコールを用いて製造した(全ての溶解を20℃で行った。)。
1.適切な大きさのガラスビーカーに水を半分入れておく
2.緑茶粉末と、クエン酸トリナトリウムを一緒に少量の水に溶解し、ガラスビーカーに加える。
3.香味料とスクラロースを少量の水に溶解し、上記ビーカーに加える。
3.アセサルフェーム Kを少量の水に溶解し、上記ビーカーに加える。
4.全ての酸(クエン酸、リンゴ酸、およびアスコルビン酸)を同時に少量の水に溶解し、ビーカーに添加する。
5.所望の質量とするために、水を添加する。
6.得られた溶液を330mlの缶に注入し、封止する。
7.卓上低温殺菌器により、缶を70℃で10分間低温殺菌する。
The product was manufactured using the following protocol (all lysis was performed at 20 ° C.).
1. Put half of the water in an appropriately sized glass beaker. Green tea powder and trisodium citrate are dissolved together in a small amount of water and added to a glass beaker.
3. Dissolve flavor and sucralose in a small amount of water and add to the beaker.
3. Dissolve acesulfame K in a small amount of water and add to the beaker.
4). All acids (citric acid, malic acid, and ascorbic acid) are simultaneously dissolved in a small amount of water and added to the beaker.
5. Water is added to achieve the desired mass.
6). The resulting solution is poured into a 330 ml can and sealed.
7). Cans are pasteurized at 70 ° C for 10 minutes using a desktop pasteurizer.
缶に詰められた製品を+5℃で一週間保存し、その後、味覚パネルにより評価した。結果を表3に示す。 The product packed in the can was stored at + 5 ° C. for one week and then evaluated by the taste panel. The results are shown in Table 3.
Claims (19)
34 < (S/C) < 115
[ここで、Sは栄養価のない甘味料の、スクロースに換算した甘さである]
を満足する量において含むことを特徴とする飲料。 A beverage having a total energy content of less than 17 kJ per 100 g and comprising catechins in an amount (C) of 0.04 to 0.4% by weight of the beverage, wherein a non-nutritive sweetener has the following conditions:
34 <(S / C) <115
[Where S is the sweetness of a non-nutritive sweetener converted to sucrose]
In a quantity that satisfies the requirements.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06291197A EP1886585B1 (en) | 2006-07-24 | 2006-07-24 | Improved beverage |
PCT/EP2007/056079 WO2008012147A1 (en) | 2006-07-24 | 2007-06-19 | Improved beverage |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2009544294A true JP2009544294A (en) | 2009-12-17 |
Family
ID=37560895
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2009521179A Pending JP2009544294A (en) | 2006-07-24 | 2007-06-19 | Improved beverage |
Country Status (20)
Country | Link |
---|---|
US (1) | US20080020020A1 (en) |
EP (2) | EP1886585B1 (en) |
JP (1) | JP2009544294A (en) |
CN (1) | CN101495001B (en) |
AR (1) | AR062041A1 (en) |
AT (1) | ATE410929T1 (en) |
AU (1) | AU2007278373B2 (en) |
CA (1) | CA2658905A1 (en) |
CL (1) | CL2007002147A1 (en) |
DE (1) | DE602006003213D1 (en) |
EG (1) | EG25604A (en) |
ES (1) | ES2313588T3 (en) |
MX (1) | MX2009000534A (en) |
MY (1) | MY143543A (en) |
PL (1) | PL1886585T3 (en) |
PT (1) | PT1886585E (en) |
RU (1) | RU2435459C2 (en) |
SA (1) | SA07280397B1 (en) |
WO (1) | WO2008012147A1 (en) |
ZA (1) | ZA200900159B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2021132054A1 (en) * | 2019-12-27 | 2021-07-01 | サントリーホールディングス株式会社 | Green tea beverage having enhanced flavor |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4838752B2 (en) * | 2006-11-13 | 2011-12-14 | 花王株式会社 | Container drink |
GB2450076B (en) * | 2007-05-17 | 2012-09-26 | Sis Science In Sport Ltd | Nutritional composition |
JP5351032B2 (en) * | 2007-09-11 | 2013-11-27 | サントリー食品インターナショナル株式会社 | Food and drink with improved sweetener taste |
JP5117148B2 (en) * | 2007-09-11 | 2013-01-09 | サントリーホールディングス株式会社 | Acidic beverages containing aspartame |
WO2009150008A1 (en) * | 2008-06-10 | 2009-12-17 | Unilever Nv | Process for preparing a tea beverage |
KR101633202B1 (en) * | 2008-06-19 | 2016-06-23 | 인터디지탈 패튼 홀딩스, 인크 | Optimized serving dual cell change |
US8178147B2 (en) * | 2008-06-26 | 2012-05-15 | Pepsico, Inc. | Coumalic acid to inhibit non-enzymatic browning in teas |
US8293299B2 (en) | 2009-09-11 | 2012-10-23 | Kraft Foods Global Brands Llc | Containers and methods for dispensing multiple doses of a concentrated liquid, and shelf stable Concentrated liquids |
US11013248B2 (en) | 2012-05-25 | 2021-05-25 | Kraft Foods Group Brands Llc | Shelf stable, concentrated, liquid flavorings and methods of preparing beverages with the concentrated liquid flavorings |
ES2980286T3 (en) * | 2016-03-31 | 2024-09-30 | Suntory Holdings Ltd | Drink containing stevia |
ES2975986T3 (en) | 2016-03-31 | 2024-07-19 | Suntory Holdings Ltd | Beverages containing a catechin compound and RebD and/or RebM |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH03164136A (en) * | 1989-08-04 | 1991-07-16 | Procter & Gamble Co:The | Improved beverage |
JPH07274829A (en) * | 1994-04-06 | 1995-10-24 | Mitsubishi Chem Corp | Tea beverage |
JPH10337154A (en) * | 1997-06-05 | 1998-12-22 | Mitsubishi Kagaku Foods Kk | Powdery soft drink |
JP2001197863A (en) * | 1996-02-26 | 2001-07-24 | Procter & Gamble Co | Extract of green tea subjected to cation exchange treatment and microfiltration so as to improve transparency and color |
JP2004159623A (en) * | 2002-12-06 | 2004-06-10 | Kao Corp | Vesseled beverage |
JP2005245351A (en) * | 2004-03-05 | 2005-09-15 | Yakult Honsha Co Ltd | Acidic beverage |
JP2006217837A (en) * | 2005-02-09 | 2006-08-24 | Kao Corp | Packaged beverage |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5464619A (en) | 1994-06-03 | 1995-11-07 | The Procter & Gamble Company | Beverage compositions containing green tea solids, electrolytes and carbohydrates to provide improved cellular hydration and drinkability |
CN1071546C (en) * | 1994-08-08 | 2001-09-26 | 普罗克特和甘保尔公司 | Color stable composition containing tea and fruit juice |
US6723369B2 (en) * | 1999-05-27 | 2004-04-20 | James M. Burgess | Carbonated beverage for strengthening acid resistancy of teeth |
WO2002011562A2 (en) * | 2000-08-08 | 2002-02-14 | Advanced Functional Foods International, Inc. | Nutritional supplement for the management of weight |
WO2002039822A2 (en) * | 2000-11-17 | 2002-05-23 | Kao Corporation | Packaged beverages |
MY135783A (en) * | 2001-09-07 | 2008-06-30 | Meiji Dairies Corp | Nutritional composition for controlling blood sugar level |
JP3378577B1 (en) | 2001-09-28 | 2003-02-17 | 花王株式会社 | Drink |
US20040096547A1 (en) * | 2002-11-15 | 2004-05-20 | Mario Ferruzzi | Healthy alternative ready-to-drink energy beverage |
US20040180077A1 (en) * | 2003-03-05 | 2004-09-16 | Riker Donald K. | Rapidly dissolving edible strips for treating obesity |
AU2004243537B2 (en) * | 2003-05-28 | 2008-01-31 | Unilever Plc | Satiety enhancing food products |
EP1628543A1 (en) * | 2003-05-28 | 2006-03-01 | Unilever N.V. | Satiety enhancing food products |
ATE440509T1 (en) * | 2003-06-04 | 2009-09-15 | Nestec Sa | DRINK FOR WEIGHT CONTROL |
AU2004257595B2 (en) * | 2003-07-03 | 2007-12-20 | The Procter & Gamble Company | Compositions containing green tea catechins and one or more polyvalent mineral cations |
US20050002989A1 (en) * | 2003-07-03 | 2005-01-06 | Slim-Fast Foods Company, Division Of Conopco, Inc. | Nutrition bar |
JP3590051B1 (en) * | 2003-07-30 | 2004-11-17 | 花王株式会社 | Packaged beverage |
AU2004267938B2 (en) * | 2003-09-03 | 2007-11-22 | Ksf Acquisition Uk Limited | Satiety enhancing food compositions |
WO2005020718A1 (en) * | 2003-09-03 | 2005-03-10 | Unilever N.V. | Satiety enhancing food compositions |
BRPI0412633A (en) * | 2003-09-03 | 2006-09-26 | Unilever Nv | edible composition, use of a biopolymer thickening agent and method for inducing satiety |
GB0320990D0 (en) * | 2003-09-08 | 2003-10-08 | Unilever Plc | Food composition |
BRPI0412634A (en) * | 2003-09-10 | 2006-09-26 | Unilever Nv | edibly composition |
JP3766670B2 (en) * | 2003-12-16 | 2006-04-12 | 花王株式会社 | Container drink |
JP4284165B2 (en) * | 2003-12-17 | 2009-06-24 | 花王株式会社 | Container drink |
US20070141219A1 (en) * | 2003-12-18 | 2007-06-21 | Kao Corporation | Bottle beverage |
DE602004025279D1 (en) * | 2003-12-18 | 2010-03-11 | Kao Corp | BOTTLE DRINK |
US20060099277A1 (en) * | 2004-10-15 | 2006-05-11 | Jewett Fred F Jr | Protein and fruit juice product |
US20060099318A1 (en) * | 2004-11-04 | 2006-05-11 | Kao Corporation | Non-tea-based, packaged beverages |
JP2006136244A (en) * | 2004-11-12 | 2006-06-01 | House Foods Corp | Powdered instant tea |
US20060188548A1 (en) * | 2004-12-14 | 2006-08-24 | Mattson Peter H | Satiety promoting beverage and use in a diet to moderate food consumption |
JP4354902B2 (en) * | 2004-12-24 | 2009-10-28 | 花王株式会社 | Purified green tea extract and high-concentrated catechin-containing beverage containing the same |
-
2006
- 2006-07-24 PL PL06291197T patent/PL1886585T3/en unknown
- 2006-07-24 PT PT06291197T patent/PT1886585E/en unknown
- 2006-07-24 EP EP06291197A patent/EP1886585B1/en active Active
- 2006-07-24 DE DE602006003213T patent/DE602006003213D1/en active Active
- 2006-07-24 ES ES06291197T patent/ES2313588T3/en active Active
- 2006-07-24 AT AT06291197T patent/ATE410929T1/en not_active IP Right Cessation
-
2007
- 2007-06-19 CN CN2007800281677A patent/CN101495001B/en active Active
- 2007-06-19 CA CA002658905A patent/CA2658905A1/en not_active Abandoned
- 2007-06-19 WO PCT/EP2007/056079 patent/WO2008012147A1/en active Application Filing
- 2007-06-19 JP JP2009521179A patent/JP2009544294A/en active Pending
- 2007-06-19 EP EP07786759A patent/EP2043462A1/en not_active Withdrawn
- 2007-06-19 MY MYPI20090317A patent/MY143543A/en unknown
- 2007-06-19 RU RU2009106054/10A patent/RU2435459C2/en active
- 2007-06-19 ZA ZA200900159A patent/ZA200900159B/en unknown
- 2007-06-19 AU AU2007278373A patent/AU2007278373B2/en not_active Ceased
- 2007-06-19 MX MX2009000534A patent/MX2009000534A/en active IP Right Grant
- 2007-07-22 SA SA7280397A patent/SA07280397B1/en unknown
- 2007-07-23 CL CL2007002147A patent/CL2007002147A1/en unknown
- 2007-07-24 AR ARP070103278A patent/AR062041A1/en not_active Application Discontinuation
- 2007-07-24 US US11/880,791 patent/US20080020020A1/en not_active Abandoned
-
2009
- 2009-01-13 EG EG2009010053A patent/EG25604A/en active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH03164136A (en) * | 1989-08-04 | 1991-07-16 | Procter & Gamble Co:The | Improved beverage |
JPH07274829A (en) * | 1994-04-06 | 1995-10-24 | Mitsubishi Chem Corp | Tea beverage |
JP2001197863A (en) * | 1996-02-26 | 2001-07-24 | Procter & Gamble Co | Extract of green tea subjected to cation exchange treatment and microfiltration so as to improve transparency and color |
JPH10337154A (en) * | 1997-06-05 | 1998-12-22 | Mitsubishi Kagaku Foods Kk | Powdery soft drink |
JP2004159623A (en) * | 2002-12-06 | 2004-06-10 | Kao Corp | Vesseled beverage |
JP2005245351A (en) * | 2004-03-05 | 2005-09-15 | Yakult Honsha Co Ltd | Acidic beverage |
JP2006217837A (en) * | 2005-02-09 | 2006-08-24 | Kao Corp | Packaged beverage |
Non-Patent Citations (4)
Title |
---|
JPN6013017432; '甘味料概論 四大人工甘味料編' 四季報[コーラ白書] , 199907 * |
JPN6013045724; 香川芳子監修: 四訂 食品成分表 , 2000, P.290-291, 女子栄養大学出版部 * |
JPN6013045725; 中林敏郎 外2名: 緑茶・紅茶・烏龍茶の化学と機能 , 1991, p.78-79 * |
JPN7013001400; 'ASPARTAME' Rapport de Projet Tutore Licence SIAL , 2004, 4ページ * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2021132054A1 (en) * | 2019-12-27 | 2021-07-01 | サントリーホールディングス株式会社 | Green tea beverage having enhanced flavor |
JP2021106522A (en) * | 2019-12-27 | 2021-07-29 | サントリーホールディングス株式会社 | Green tea beverage with enhanced flavor |
Also Published As
Publication number | Publication date |
---|---|
CN101495001B (en) | 2013-03-27 |
EP1886585A1 (en) | 2008-02-13 |
EP1886585B1 (en) | 2008-10-15 |
AR062041A1 (en) | 2008-08-10 |
PL1886585T3 (en) | 2009-04-30 |
ES2313588T3 (en) | 2009-03-01 |
SA07280397B1 (en) | 2010-10-19 |
MX2009000534A (en) | 2009-01-27 |
CN101495001A (en) | 2009-07-29 |
AU2007278373A1 (en) | 2008-01-31 |
CA2658905A1 (en) | 2008-01-31 |
WO2008012147A1 (en) | 2008-01-31 |
US20080020020A1 (en) | 2008-01-24 |
ZA200900159B (en) | 2010-05-26 |
ATE410929T1 (en) | 2008-10-15 |
RU2435459C2 (en) | 2011-12-10 |
MY143543A (en) | 2011-05-31 |
DE602006003213D1 (en) | 2008-11-27 |
EG25604A (en) | 2012-03-20 |
CL2007002147A1 (en) | 2008-01-25 |
PT1886585E (en) | 2008-11-03 |
EP2043462A1 (en) | 2009-04-08 |
RU2009106054A (en) | 2010-08-27 |
AU2007278373B2 (en) | 2010-09-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2009544294A (en) | Improved beverage | |
JP3162359B2 (en) | Improved beverage | |
US8088429B2 (en) | Package drink | |
JP4569965B2 (en) | Method for producing purified green tea extract | |
JP4726269B2 (en) | Oral solution | |
TWI492715B (en) | Containing polymerized catechins | |
JP4562682B2 (en) | Method for producing purified green tea extract | |
JP2005058209A (en) | Drink packed into container | |
MXPA04012958A (en) | Isomaltulose-containing instant beverage powder. | |
JP4284165B2 (en) | Container drink | |
JP3615213B1 (en) | Container drink | |
JP2005160368A (en) | Packaged beverage | |
TWI826626B (en) | Container-packed tea beverage and manufacturing method thereof | |
JP2006166771A (en) | Packaged beverage | |
JP2009065872A (en) | Polymerized catechin-containing drink | |
JP4840003B2 (en) | Oral composition | |
JP3481246B2 (en) | Bitter and astringency enhancement method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20100608 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20120120 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120403 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20120629 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20120706 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130416 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130704 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130917 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20140304 |